Covidien announced the launch of its 1 in 1,000 campaign to help educate women about the risk of pregnancy-related blood clots, one of the leading causes of maternal mortality in the developed world. The announcement was made at the 2012 annual meeting of the Association of Women s Health, Obstetric and Neonatal Nurses
With the University of Pittsburgh s development of a cell-free, biodegradable artery graft comes a potentially transformative change in coronary artery bypass surgeries: Within 90 days after surgery, the patient will have a regenerated artery with no trace of synthetic graft materials left in the body.
There has been a three-fold increase in the number of patients receiving acute dialysis because of injury after cardiac and vascular surgeries since 1995, states a new study in CMAJ (Canadian Medical Association Journal).
Acute kidney injury appears to be an increasing problem in cardiac and vascular surgeries, researchers found. Severe cases marked by need for acute dialysis after major elective surgery -- although rare -- rose year over year from a rate of 0.2% in 1995 to 0.6% in 2009, Amit X. Garg, MD, PhD, of Western University in London, Ontario, and colleagues reported.
The US Food and Drug Administration (FDA) recently selected an investigational stent graft for endovascular treatment of thoracic aortic aneurysms involving branch vessel. The device would be used inan early feasibility pilot programme.
Regulatory Agency Selects Investigational Medical Device for Endovascular Treatment of Thoracic Aortic Aneurysms Involving Branch Vessel for Early Feasibility Pilot Program
The UNC Center for Heart & Vascular Care’s Aortic Disease Management team is the first in the USA to use a new FDA-approved device to successfully treat a complex abdominal aortic aneurysm (AAA).
The Sandwich Technique, developed to overcome current anatomical and device constraints, could expand the limits of endovascular aneurysm repair (EVAR) in a safe, easy to perform, and cost-effective manner, Armando Lobato, ICVE, Sao Paulo Vascular & Endovascular Surgery Institute, Beneficencia Portuguesa Hospital, Sao Paulo, Brazil, told delegates at the Society for Vascular Surgery Annual Meeting in Washington DC, USA.
MAQUET Cardiovascular, LLC announced today that it has received CE mark for its INTERGARD SYNERGY vascular graft. This graft represents the next generation in antimicrobial grafts combining the well-known antimicrobial properties of silver acetate and triclosan. The INTERGARD SYNERGY graft will be commercially available immediately within countries that recognize the CE mark.
Avinger has announced that it has successfully completed enrolment in its CONNECT II global clinical trial. A study focused on treatment of peripheral artery disease. CONNECT II is a prospective, multicentre, non-randomised global clinical study that evaluated 100 peripheral artery disease patients with femoropopliteal chronic total occlusion lesions at 15 hospital and clinic sites, including two in the European Union.
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), shared 12-month data from the COMPLIANCE 360 study of severely calcified above-the-knee lesions at the New Cardiovascular Horizons Annual Conference on Saturday, June 9, 2012. Dr. Barry Weinstock, Interventional Cardiologist, Orlando Regional Medical Center, Winter Park, Fla., presented data demonstrating positive outcomes and cost comparisons to the widely used percutaneous transluminal angioplasty (PTA).
In its first human trial, the mechanochemical ablation (MOCA) catheter was efficacious at two years as current endothermal techniques, but without the need of tumescent anesthesia. In addition, MOCA was more effective than results of foam sclerotherapy of the great saphenous vein (GSV) and is another alternative modality for most incompetent GSV s and small saphenous veins (SSV s). Detailed results were presented today at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery®.
Lombard today announced the high angle clinical data results from the US PYTHAGORAS trial of its endovascular stent graft Aorfix. Data suggest that Aorfix has the potential to provide a less invasive treatment option for abdominal aortic aneurysm patients with highly angulated neck anatomy.
Researchers from Stanford University s Goodman Simulation Center in the Department of Surgery in Palo Alto, CA, revealed the results of endovascular skills training provided to their surgical residents today at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery®.
While carotid endarterectomy (CEA) is performed to prevent stroke, long-term survival is essential to ensure benefit, especially in asymptomatic patients. A new study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery® today examined patient factors associated with 5-year survival following CEA in patients with asymptomatic internal carotid artery (ICA) stenosis.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos